EPISODE · May 13, 2026 · 1H 8M
are we there yet?
from outfield · host Robert Infield
The podcast episode delves into the potential benefits and risks of Ibogaine as a treatment for addiction, exploring its psychedelic properties, breathwork, clinical trials, and the future of Ibogaine treatment. The conversation also touches on the monetization of Ibogaine and its impact on the addiction treatment industry. The conversation covers a range of topics, including population misconceptions, conspiracy theories, government distrust, workplace safety, hazard pay, addiction treatment, and clinical trials. The discussion delves into the misconceptions about the world's population, anxiety around phone calls, and the impact of conspiracy theories on public trust. It also explores workplace safety concerns, the concept of universal basic income, financial responsibility, and the importance of clinical trials in addiction treatment. Takeaways Ibogaine as a Treatment Psychedelic Therapy Population Misconceptions Anxiety Around Phone Calls Conspiracy Theories and Government Distrust Workplace Safety and Hazard Pay Addiction Treatment and Clinical Trials Chapters 00:00 Introduction and Podcast Overview 06:00 Breathwork and DMT Release 12:54 Ibogaine as an Alternative to Methadone and Suboxone 21:07 Monetization and Future of Ibogaine Treatment 36:05 Population Misconceptions 42:18 Conspiracy Theories and Government Distrust 49:09 Assassination Theories and Suspicion 59:20 Workplace Safety and Hazard Pay 01:06:08 Addiction Treatment and Clinical Trials
Embed this episode
Ready to play
are we there yet?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.